(Q42994815)

English

Selection of genetic variants of the 5' noncoding region of hepatitis C virus occurs only in patients responding to interferon alpha therapy

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Selection of genetic variants of the 5' noncoding region of hepatitis C virus occurs only in patients responding to interferon alpha therapy (English)

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Lu M

1

1 reference

Europe PubMed Central

12 November 2017

Wiese M

2

1 reference

Europe PubMed Central

12 November 2017

Roggendorf M

3

1 reference

Europe PubMed Central

12 November 2017

publication date

1 October 1999

1 reference

Europe PubMed Central

12 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

12 November 2017

59

1 reference

Europe PubMed Central

12 November 2017

2

1 reference

Europe PubMed Central

12 November 2017

146-153

1 reference

Europe PubMed Central

12 November 2017

Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Therapy of Hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Current state of interferon therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Different susceptibilities of genetic variants of hepatitis C virus (HCV) to interferon (IFN).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

The "interferon sensitivity determining region" of hepatitis C virus is a stable sequence element

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Selection of hepatitis C virus quasispecies during interferon treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Restriction of hepatitis C virus heterogeneity during prolonged interferon-alpha therapy in relation to changes in virus load

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

HCV genotypes in chronic hepatitis C and response to interferon

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199910%2959%3A2%3C146%3A%3AAID-JMV4%3E3.0.CO%3B2-O

21 January 2018

Identifiers

10.1002/(SICI)1096-9071(199910)59:2<146::AID-JMV4>3.0.CO;2-O

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42994815&oldid=1976276889"